Mesoblast Limited Gains 46.67%
Mon, Apr 06, 2020 at 05:30 PM
Mesoblast Limited (MESO:NASDAQ) jumped higher at $6.16, a gain of 46.7%. The stock got featured on our News Catalysts scanner on Mon 06 Apr 20 at 07:00 AM in the 'BIOTECH' category. From Fri 20 Mar 20, the stock recorded 60.00% Up Days and 27.27% Green Days
About Mesoblast Limited (MESO:NASDAQ)
Mesoblast Ltd is engaged in the development of biologic products for the broad field of regenerative medicine. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells.
Top 10 Gainers:
- Akers Biosciences, Inc. (AKER:NASDAQ), 146.84%
- Immunomedics, Inc. (IMMU:NASDAQ), 99.79%
- Exantas Capital Corp. (XAN:NYSE), 57.55%
- Aeterna Zentaris Inc. (AEZS:NASDAQ), 55.72%
- Associated Capital Group, Inc. (AC:NYSE), 48.82%
- Mesoblast Limited (MESO:NASDAQ), 46.67%
- Atossa Therapeutics, Inc. (ATOS:NASDAQ), 44.23%
- Braemar Hotels & Resorts, Inc. (BHR:NYSE), 43.55%
- Pensare Acquisition Corp. (WRLS:NASDAQ), 43.33%
- Cherry Hill Mortgage Investment Corporation (CHMI:NYSE), 41.52%